{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:44:39Z","timestamp":1773013479960,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pharep.2013.09.004","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T20:15:17Z","timestamp":1393704917000},"page":"235-238","source":"Crossref","is-referenced-by-count":22,"title":["ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population"],"prefix":"10.1007","volume":"66","author":[{"given":"Gul","family":"Ozbey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap E.","family":"Taycan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurdan E.","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyibe","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"Percin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevzat","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt","family":"Guzey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Uluoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.09.004_bib0005","first-page":"241","article-title":"Citalopram\u2014a review of pharmacological and clinical effects","volume":"25","author":"Bezchlibnyk-Butler","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharep.2013.09.004_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","article-title":"Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells","volume":"47","author":"Chen","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.pharep.2013.09.004_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/S1461145709009894","article-title":"Locally increased P-glycoprotein function in major depression: a PET study with [11C] verapamil as a probe for P-glycoprotein function in the blood\u2013brain barrier","volume":"12","author":"De Klerk","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2013.09.004_bib0020","first-page":"269","article-title":"Brain corticosteroid receptor balance in health and disease","volume":"19","author":"De Kloet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharep.2013.09.004_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2008.03.004","article-title":"Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene","volume":"80","author":"Dericioglu","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00007691-200310000-00005","article-title":"A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs","volume":"25","author":"Duverneuil","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharep.2013.09.004_bib0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.09.004_bib0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpsychires.2012.01.012","article-title":"Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population","volume":"46","author":"Fujii","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2013.09.004_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.DMPK-11-RV-098","article-title":"Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP ABCG2)","volume":"27","author":"Ieiri","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharep.2013.09.004_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.20427","article-title":"Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients","volume":"80","author":"Kaya","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pharep.2013.09.004_bib0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.tpj.6500025","article-title":"The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels","volume":"1","author":"Kerb","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharep.2013.09.004_bib0065","first-page":"35","article-title":"Frequency of common MDR1 gene variants in a Polish population","volume":"58","author":"Kurzawski","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.09.004_bib0070","first-page":"136","article-title":"CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups","volume":"66","author":"Lai","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharep.2013.09.004_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31887\/DCNS.2011.13.1\/jlicinio","article-title":"Pharmacogenomics of antidepressant treatment effects","volume":"13","author":"Licinio","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.pharep.2013.09.004_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/FPC.0b013e32833db216","article-title":"ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment","volume":"21","author":"Lin","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pharep.2013.09.004_bib0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0090","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1734-1140(11)70593-X","article-title":"Frequency of the C1236T G2677T\/A and C3435T MDR1 gene polymorphisms in the Serbian population","volume":"63","author":"Milojkovic","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.09.004_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2008.09.010","article-title":"Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study","volume":"58","author":"Nikisch","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O\u2019Brien","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2013.09.004_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10253890500069650","article-title":"Glucocorticoid receptor function in vitro in patients with major depression","volume":"7","author":"Pariante","year":"2004","journal-title":"Stress"},{"key":"10.1016\/j.pharep.2013.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1371\/journal.pone.0001872","article-title":"Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample","volume":"3","author":"Peters","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2013.09.004_bib0115","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1248\/bpb.29.2446","article-title":"MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression","volume":"29","author":"Qian","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharep.2013.09.004_bib0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cbf.1788","article-title":"Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population","volume":"29","author":"Rideg","year":"2011","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.pharep.2013.09.004_bib0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.tpj.6500099","article-title":"A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression","volume":"2","author":"Roberts","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharep.2013.09.004_bib0130","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.4238\/2011.December.14.7","article-title":"Analysis of common MDR1 (ABCB1) gene C1236T and C3435T polymorphisms in Turkish patients with familial Mediterranean fever","volume":"10","author":"Rustemoglu","year":"2011","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.20.391","article-title":"MDR1 genotype-related pharmacokinetics: fact or fiction?","volume":"20","author":"Sakaeda","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharep.2013.09.004_bib0140","first-page":"27","article-title":"Major depressive disorder: remission of associated symptoms","volume":"67","author":"Trivedi","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2013.09.004_bib0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11033-006-9022-x","article-title":"Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey","volume":"33","author":"Turgut","year":"2006","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharep.2013.09.004_bib0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3956(03)00022-0","article-title":"abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice","volume":"37","author":"Uhr","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharep.2013.09.004_bib0155","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-3223(03)00074-X","article-title":"Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption","volume":"54","author":"Uhr","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.09.004_bib0160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2826.2002.00836.x","article-title":"Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins","volume":"14","author":"Uhr","year":"2002","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharep.2013.09.004_bib0165","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0893-133X(99)00095-0","article-title":"Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption","volume":"22","author":"Uhr","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2013.09.004_bib0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharep.2013.09.004_bib0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1208\/aapsj080361","article-title":"Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1)","volume":"8","author":"Wang","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.pharep.2013.09.004_bib0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.09.004_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408360701713112","article-title":"Relevant issues in the monitoring and the toxicology of antidepressants","volume":"45","author":"Wille","year":"2008","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:16Z","timestamp":1752611716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.09.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1734114014000395"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.09.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}